Musculoskeletal disorders causing temporary work disability. Musculoskeletal Diseases
Conditions
Interventions
The intervention was a specific clinical program. The control group received standard care.
At the first 45-minute visit, patients received a specific diagnosis, reassurance that no serious disease
Sponsors
The Carlos III Health Institute (Instituto de Salud Carlos III) (Spain)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The issue of a ?common diseases? temporary work disability initiation form, with an MSD-related cause reported by the primary care physician. The MSD-related causes included the following: 1. All arthropathies 2. Connective tissue disorders 3. Back disorders 4. Soft-tissue rheumatisms 5. Bone and cartilage disorders 6. Musculoskeletal pain not caused by cancer 7. Nerve entrapment syndromes
Exclusion criteria
Exclusion criteria: 1. Patients who had ?common diseases? temporary work disability form with an MSD-related cause resulting from trauma or surgery. 2. Patients who had ?work accidents? or ?professional diseases? noted on the temporary work disability initiation form. Work accidents are primarily sudden, external, violent causes of disease occurring at work or during travel to work, and they represent less than 27% of cases of temporary work disability. Professional diseases include silicosis, asbestos-related mesotelioma, and noise-induced hearing loss, and they represent less than 1% of cases of temporary work disability.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy was defined as the differences between groups in the following: 1. Duration of all episodes of MSD-related temporary work disability 2. Number of episodes of MSD-related temporary work disability per patient, assessed one year after the end of inclusion period 3. Number and outcome of proposals for permanent work disability | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Relative efficacy is expressed as the percentage of days on temporary work disability saved per patient and as the total number of days on temporary work disability saved in the intervention group (number of episodes in the intervention group x [mean duration of episodes in control group - mean duration of episodes in intervention group]). 2. Cost-efficacy was defined as the amount of money required to save 1 day of temporary work disability. 3. Cost-benefit was defined as dollars invested divided by dollars saved. Net benefit was defined as dollars saved minus dollars invested. | — |
Countries
Spain
Outcome results
None listed